Research review underscores progress in treating kidney cancer, importance of close patient monitoring
With the swift introduction of approved immunotherapy approaches into the treatment landscape for many cancers,…
Browsing: Kidney Cancer
ESMO 2018: Avelumab plus axitinib significantly improve PFS in untreated renal cell carcinoma
A combination of the immune checkpoint blocker, , plus the tyrosine kinase inhibitor (TKI), axitinib,…
New nanotherapy offers hope in treating drug-resistant renal cell carcinoma
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the…
Blood test could detect kidney cancer up to 5 years earlier
Scientists have discovered that a marker in the blood could help predict the risk that…
My Top 3 ASCO Abstracts by Prunella Blinman
I love a good plenary session at ASCO, and this year’s plenary session was one…
Phase III Trial Finds Many People With Advanced Kidney Cancer Do Not Need Surgery
A randomized phase III clinical trial showed that many people with advanced kidney cancer can…
How tumour donations from patients help scientists understand cancer
“You don’t exactly want your tumour to take home and stick on your mantelpiece -…
First seeds of kidney cancer sown in adolescence
The earliest critical genetic changes that can lead to kidney cancer have been mapped by…
For women with kidney cancer, belly fat matters
Belly fat affects the odds of women surviving kidney cancer but not men, according to…
Combo immunotherapy may herald new standard of care for kidney cancer
Combination therapy with two immunotherapy drugs produces an unprecedented doubling of response rates from 20…